Anteris Technologies Global Corp. cash flow statement
In fiscal 2025, Anteris Technologies Global Corp.'s operations generated −$77.8m of cash; it spent $2.0m on capital projects, leaving free cash flow of −$79.8m.
Cash flow statement
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −14 | −18 | −21 | −20 | −18 | −19 | −29 | −21 |
| Depreciation and amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based pay | 2 | 1 | 2 | 2 | 2 | 3 | 2 | 4 |
| Capital spending | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 1 |
| Free cash flow | −15 | −19 | −22 | −20 | −19 | −19 | −29 | −21 |
| Free cash flow after stock pay | −16 | −20 | −23 | −22 | −21 | −22 | −31 | −25 |
| Shares issued | 20 | 89 | 1 | 0 | 0 | 25 | — | — |
Compare with peers
- Femasys Inc cash flow
- Volitionrx LTD cash flow
- Seastar Medical Holding Corp cash flow
- Insight Molecular Diagnostics Inc. cash flow
- Icecure Medical Ltd. cash flow
Head to head: AVR vs FEMYAVR vs VNRXAVR vs ICU
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies